These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 20047280)
1. Novel synthesis of the hexahydroimidazo[1,5b]isoquinoline scaffold: application to the synthesis of glucocorticoid receptor modulators. Xiao HY; Wu DR; Malley MF; Gougoutas JZ; Habte SF; Cunningham MD; Somerville JE; Dodd JH; Barrish JC; Nadler SG; Dhar TG J Med Chem; 2010 Feb; 53(3):1270-80. PubMed ID: 20047280 [TBL] [Abstract][Full Text] [Related]
2. Dissociated nonsteroidal glucocorticoid receptor modulators; discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series. Barker M; Clackers M; Copley R; Demaine DA; Humphreys D; Inglis GG; Johnston MJ; Jones HT; Haase MV; House D; Loiseau R; Nisbet L; Pacquet F; Skone PA; Shanahan SE; Tape D; Vinader VM; Washington M; Uings I; Upton R; McLay IM; Macdonald SJ J Med Chem; 2006 Jul; 49(14):4216-31. PubMed ID: 16821781 [TBL] [Abstract][Full Text] [Related]
3. 2-Benzenesulfonyl-8a-benzyl-hexahydro-2H-isoquinolin-6-ones as selective glucocorticoid receptor antagonists. Clark RD; Ray NC; Blaney P; Crackett PH; Hurley C; Williams K; Dyke HJ; Clark DE; Lockey PM; Devos R; Wong M; White A; Belanoff JK Bioorg Med Chem Lett; 2007 Oct; 17(20):5704-8. PubMed ID: 17822897 [TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal glucocorticoid agonists: tetrahydronaphthalenes with alternative steroidal A-ring mimetics possessing dissociated (transrepression/transactivation) efficacy selectivity. Biggadike K; Boudjelal M; Clackers M; Coe DM; Demaine DA; Hardy GW; Humphreys D; Inglis GG; Johnston MJ; Jones HT; House D; Loiseau R; Needham D; Skone PA; Uings I; Veitch G; Weingarten GG; McLay IM; Macdonald SJ J Med Chem; 2007 Dec; 50(26):6519-34. PubMed ID: 18038970 [TBL] [Abstract][Full Text] [Related]
5. Discovery and SAR study of novel dihydroquinoline containing glucocorticoid receptor ligands. Takahashi H; Bekkali Y; Capolino AJ; Gilmore T; Goldrick SE; Nelson RM; Terenzio D; Wang J; Zuvela-Jelaska L; Proudfoot J; Nabozny G; Thomson D Bioorg Med Chem Lett; 2006 Mar; 16(6):1549-52. PubMed ID: 16386422 [TBL] [Abstract][Full Text] [Related]
6. The design, synthesis and structure-activity relationships of 1-aryl-4-aminoalkylisoquinolines: a novel series of CRF-1 receptor antagonists. Yoon T; De Lombaert S; Brodbeck R; Gulianello M; Chandrasekhar J; Horvath RF; Ge P; Kershaw MT; Krause JE; Kehne J; Hoffman D; Doller D; Hodgetts KJ Bioorg Med Chem Lett; 2008 Feb; 18(3):891-6. PubMed ID: 18180159 [TBL] [Abstract][Full Text] [Related]
7. Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826). Weinstein DS; Gong H; Doweyko AM; Cunningham M; Habte S; Wang JH; Holloway DA; Burke C; Gao L; Guarino V; Carman J; Somerville JE; Shuster D; Salter-Cid L; Dodd JH; Nadler SG; Barrish JC J Med Chem; 2011 Oct; 54(20):7318-33. PubMed ID: 21899328 [TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines. Kym PR; Kort ME; Coghlan MJ; Moore JL; Tang R; Ratajczyk JD; Larson DP; Elmore SW; Pratt JK; Stashko MA; Falls HD; Lin CW; Nakane M; Miller L; Tyree CM; Miner JN; Jacobson PB; Wilcox DM; Nguyen P; Lane BC J Med Chem; 2003 Mar; 46(6):1016-30. PubMed ID: 12620078 [TBL] [Abstract][Full Text] [Related]
9. A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds. van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; Ijzerman AP J Med Chem; 1998 Oct; 41(21):3994-4000. PubMed ID: 9767637 [TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of new nonsteroidal glucocorticoid modulators through application of an "agreement docking" method. Barker M; Clackers M; Demaine DA; Humphreys D; Johnston MJ; Jones HT; Pacquet F; Pritchard JM; Salter M; Shanahan SE; Skone PA; Vinader VM; Uings I; McLay IM; Macdonald SJ J Med Chem; 2005 Jul; 48(14):4507-10. PubMed ID: 15999989 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticonvulsant evaluation of N-substituted isoquinoline AMPA receptor antagonists. Gitto R; De Luca L; Pagano B; Citraro R; De Sarro G; Costa L; Ciranna L; Chimirri A Bioorg Med Chem; 2008 Mar; 16(5):2379-84. PubMed ID: 18077172 [TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid activation of chromogranin A gene expression. Identification and characterization of a novel glucocorticoid response element. Rozansky DJ; Wu H; Tang K; Parmer RJ; O'Connor DT J Clin Invest; 1994 Dec; 94(6):2357-68. PubMed ID: 7989592 [TBL] [Abstract][Full Text] [Related]
13. The first X-ray crystal structure of the glucocorticoid receptor bound to a non-steroidal agonist. Madauss KP; Bledsoe RK; Mclay I; Stewart EL; Uings IJ; Weingarten G; Williams SP Bioorg Med Chem Lett; 2008 Dec; 18(23):6097-9. PubMed ID: 18952422 [TBL] [Abstract][Full Text] [Related]
14. Discovery of novel dihydro-9,10-ethano-anthracene carboxamides as glucocorticoid receptor modulators. Yang BV; Vaccaro W; Doweyko AM; Doweyko LM; Huynh T; Tortolani D; Nadler SG; McKay L; Somerville J; Holloway DA; Habte S; Weinstein DS; Barrish JC Bioorg Med Chem Lett; 2009 Apr; 19(8):2139-43. PubMed ID: 19321341 [TBL] [Abstract][Full Text] [Related]
15. Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome. Bonovich MT; List HJ; Zhang S; Danielsen M; Riegel AT Exp Cell Res; 1998 Mar; 239(2):454-62. PubMed ID: 9521864 [TBL] [Abstract][Full Text] [Related]
16. Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activity. Ali A; Thompson CF; Balkovec JM; Graham DW; Hammond ML; Quraishi N; Tata JR; Einstein M; Ge L; Harris G; Kelly TM; Mazur P; Pandit S; Santoro J; Sitlani A; Wang C; Williamson J; Miller DK; Thompson CM; Zaller DM; Forrest MJ; Carballo-Jane E; Luell S J Med Chem; 2004 May; 47(10):2441-52. PubMed ID: 15115388 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting. Tran T; Shatnawi A; Zheng X; Kelley KM; Ratnam M Cancer Res; 2005 May; 65(10):4431-41. PubMed ID: 15899836 [TBL] [Abstract][Full Text] [Related]
18. 1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity. Clark RD; Ray NC; Williams K; Blaney P; Ward S; Crackett PH; Hurley C; Dyke HJ; Clark DE; Lockey P; Devos R; Wong M; Porres SS; Bright CP; Jenkins RE; Belanoff J Bioorg Med Chem Lett; 2008 Feb; 18(4):1312-7. PubMed ID: 18226897 [TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid. Wright MC; Wang XJ; Pimenta M; Ribeiro V; Paine AJ; Lechner MC Mol Pharmacol; 1996 Oct; 50(4):856-63. PubMed ID: 8863830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]